Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Antidepressant-associated chronic irritable dysphoria (ACID) in STEP-BD patients.

El-Mallakh RS, Ghaemi SN, Sagduyu K, Thase ME, Wisniewski SR, Nierenberg AA, Zhang HW, Pardo TA, Sachs G; STEP-BD Investigators.

J Affect Disord. 2008 Dec;111(2-3):372-7. doi: 10.1016/j.jad.2008.03.025. Epub 2008 Jun 20.

PMID:
18565592
2.

Antidepressant-associated chronic irritable dysphoria (acid) in bipolar disorder: a case series.

Ei-Mallakh RS, Karippot A.

J Affect Disord. 2005 Feb;84(2-3):267-72.

PMID:
15708425
3.

The prospective course of rapid-cycling bipolar disorder: findings from the STEP-BD.

Schneck CD, Miklowitz DJ, Miyahara S, Araga M, Wisniewski S, Gyulai L, Allen MH, Thase ME, Sachs GS.

Am J Psychiatry. 2008 Mar;165(3):370-7; quiz 410. doi: 10.1176/appi.ajp.2007.05081484. Epub 2008 Jan 15.

PMID:
18198271
4.

Self-reported history of manic/hypomanic switch associated with antidepressant use: data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).

Truman CJ, Goldberg JF, Ghaemi SN, Baldassano CF, Wisniewski SR, Dennehy EB, Thase ME, Sachs GS.

J Clin Psychiatry. 2007 Oct;68(10):1472-9.

PMID:
17960960
5.

Are antidepressants associated with new-onset suicidality in bipolar disorder? A prospective study of participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).

Bauer MS, Wisniewski SR, Marangell LB, Chessick CA, Allen MH, Dennehy EB, Miklowitz DJ, Thase ME, Sachs GS.

J Clin Psychiatry. 2006 Jan;67(1):48-55.

PMID:
16426088
6.

Psychopharmacological treatment of depression, anxiety, irritability and insomnia in patients receiving interferon-alpha: a prospective case series and a discussion of biological mechanisms.

Maddock C, Baita A, Orrù MG, Sitzia R, Costa A, Muntoni E, Farci MG, Carpiniello B, Pariante CM.

J Psychopharmacol. 2004 Mar;18(1):41-6.

PMID:
15107183
7.

[Clinical relevance of antidepressant-induced activation syndrome: from a perspective of bipolar spectrum disorder].

Tanaka T, Inoue T, Suzuki K, Kitaichi Y, Masui T, Denda K, Koyama T.

Seishin Shinkeigaku Zasshi. 2007;109(8):730-42. Japanese.

PMID:
17969991
8.

Antidepressant-associated mood elevations in bipolar II disorder compared with bipolar I disorder and major depressive disorder: a systematic review and meta-analysis.

Bond DJ, Noronha MM, Kauer-Sant'Anna M, Lam RW, Yatham LN.

J Clin Psychiatry. 2008 Oct;69(10):1589-601. Review.

PMID:
19192442
9.

Clinical features of antidepressant associated manic and hypomanic switches in bipolar disorder.

Serretti A, Artioli P, Zanardi R, Rossini D.

Prog Neuropsychopharmacol Biol Psychiatry. 2003 Aug;27(5):751-7.

PMID:
12921905
10.

Bipolar depression: relationship between episode length and antidepressant treatment.

Frankle WG, Perlis RH, Deckersbach T, Grandin LD, Gray SM, Sachs GS, Nierenberg AA.

Psychol Med. 2002 Nov;32(8):1417-23.

PMID:
12455940
11.

Only half of bipolar I and II patients report prodromal symptoms.

Mantere O, Suominen K, Valtonen HM, Arvilommi P, Isometsä E.

J Affect Disord. 2008 Dec;111(2-3):366-71. doi: 10.1016/j.jad.2008.03.011. Epub 2008 Apr 28.

PMID:
18442858
12.

Predictors of switching from mania to depression in a large observational study across Europe (EMBLEM).

Vieta E, Angst J, Reed C, Bertsch J, Haro JM; EMBLEM advisory board.

J Affect Disord. 2009 Nov;118(1-3):118-23. doi: 10.1016/j.jad.2009.02.007. Epub 2009 Mar 9.

PMID:
19269690
13.

Antidepressant treatment-emergent affective switch in bipolar disorder: a prospective case-control study of outcome.

Tamada RS, Amaral JA, Issler CK, Nierenberg AA, Lafer B.

Rev Bras Psiquiatr. 2006 Dec;28(4):297-300.

14.

Adjunctive antidepressant use and symptomatic recovery among bipolar depressed patients with concomitant manic symptoms: findings from the STEP-BD.

Goldberg JF, Perlis RH, Ghaemi SN, Calabrese JR, Bowden CL, Wisniewski S, Miklowitz DJ, Sachs GS, Thase ME.

Am J Psychiatry. 2007 Sep;164(9):1348-55.

PMID:
17728419
15.

Depressive illness burden associated with complex polypharmacy in patients with bipolar disorder: findings from the STEP-BD.

Goldberg JF, Brooks JO 3rd, Kurita K, Hoblyn JC, Ghaemi SN, Perlis RH, Miklowitz DJ, Ketter TA, Sachs GS, Thase ME.

J Clin Psychiatry. 2009 Feb;70(2):155-62. Epub 2009 Feb 10.

PMID:
19210946
16.

Testing definitions of dysphoric mania and hypomania: prevalence, clinical characteristics and inter-episode stability.

Bauer MS, Whybrow PC, Gyulai L, Gonnel J, Yeh HS.

J Affect Disord. 1994 Nov;32(3):201-11.

PMID:
7852662
17.

Antidepressant-associated switches from depression to mania in severe bipolar disorder.

Carlson GA, Finch SJ, Fochtmann LJ, Ye Q, Wang Q, Naz B, Bromet EJ.

Bipolar Disord. 2007 Dec;9(8):851-9.

PMID:
18076534
18.

[The relationship of affective temperament and clinical features in bipolar disorder].

Kesebir S, Vahip S, Akdeniz F, Yüncü Z.

Turk Psikiyatri Derg. 2005 Fall;16(3):164-9. Turkish.

19.

A case series on the hypothesized connection between dementia and bipolar spectrum disorders: bipolar type VI?

Ng B, Camacho A, Lara DR, Brunstein MG, Pinto OC, Akiskal HS.

J Affect Disord. 2008 Apr;107(1-3):307-15. Epub 2007 Sep 21.

PMID:
17889374
20.

Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126).

Vieta E, Suppes T, Eggens I, Persson I, Paulsson B, Brecher M.

J Affect Disord. 2008 Aug;109(3):251-63. doi: 10.1016/j.jad.2008.06.001. Epub 2008 Jun 24.

PMID:
18579216

Supplemental Content

Support Center